Filing Details
- Accession Number:
- 0001209191-16-090771
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-11 16:17:51
- Reporting Period:
- 2016-01-11
- Filing Date:
- 2016-01-11
- Accepted Time:
- 2016-01-11 16:17:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1280600 | Acceleron Pharma Inc | XLRN | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 816284 | Celgene Corp /De/ | 86 Morris Avenue Summit NJ 07901 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-01-11 | 800,000 | $40.00 | 5,372,887 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
